- Home
- Products and Services
- AHFS Classification – Drug Assignments
AHFS Classification – Drug Assignments
The following describes drug assignments and changes to the AHFS Pharmacologic-Therapeutic Classification©. This is only a partial listing of the AHFS classification system. The full classification, along with a list of drugs covered in AHFS DI and their corresponding classes, is available in the print edition of AHFS and electronically as a dataset that can be licensed. Reproduction, storage on a retrieval system, or transmission of this material or any part thereof in any form or by any means without the express written permission of the American Society of Health-System Pharmacists is prohibited.
Please contact us at ahfs@ashp.org if you have any questions.
AHFS Drug Assignments
| Drug Name | Active Ingredients | Company | Indication | Approval Date | AHFS Class | NDA Type | Appl No |
|---|---|---|---|---|---|---|---|
| Zevaskyn | prademagene zamikeracel | Abeona Therapeutics Inc. | Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa | 04/29/2025 | 26:12 - Gene Therapy; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | ||
| Imaavy | nipocalimab-aahu | Janssen Biotech, Inc. | Generalized Myasthenia Gravis (gMG) | 04/29/2025 | 90:08.04 - Neonatal Fc Receptor Blockers | BLA | 761430 |
| Penpulimab-kcqx | Akeso, Inc. | Advanced Nasopharyngeal Carcinoma | 04/23/2025 | 10:00 - Antineoplastic Agents | BLA/O | 761258 | |
| Vanrafia | atrasentan | Novartis Pharmaceuticals Corp | Proteinuria Reduction in Primary IgA Nephropathy | 04/02/2025 | 48:48.12 - Endothelin receptor antagonists | 1P | 219208 |
| Qfitlia | fitusiran | Genzyme corp | Hemophilia A or B With or Without Inhibitors | 03/28/2025 | 20:28.16 - Hemostatics | 1S/O | 219019 |
| Vykat XR | diazoxide choline | Soleno Therapeutics, Inc. | Hyperphagia in Prader-Willi Syndrome | 03/26/2025 | 28:20.92 - Anorexigenic Agents and Stimulants, Miscellaneous | 2P/O | 216665 |
| Blujepa | gepotidacin | GSK | Uncomplicated Urinary Tract Infections | 03/25/2025 | 8:12.28.36 - Triazaacenaphthylenes | 1P | 218230 |
| Encelto | revakinagene taroretcel-lwey | Neurotech Pharmaceuticals, Inc. | Macular Telangiectasia Type 2 (MacTel) | 03/06/2025 | 26:12 - Gene Therapy; 52:92 - EENT Drugs, Miscellaneous | ||
| Vimkunya | chikungunya vaccine, recombinant | Bavarian Nordic A/S | Prevention of Disease Caused by Chikungunya Virus | 02/14/2025 | 80:12 - Vaccines | ||
| Romvimza | vimseltinib | Ono Pharmaceutical Co., Ltd. | Symptomatic Tenosynovial Giant Cell Tumor | 02/14/2025 | 10:00 - Antineoplastic Agents | 1P |
Showing 1 to 10 of 1,074 entries